Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Progressive Glioblastoma
Philadelphia, Pennsylvania
Progressive Glioblastoma Clinical Trials in Philadelphia, Pennsylvania
1 recruiting
Philadelphia, Pennsylvania
Showing
1–1
of
1
trials
Recruiting
Phase 2
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Recurrent Glioblastoma
Progressive Glioblastoma
National Cancer Institute (NCI)
184 enrolled
324 locations
NCT06325683
Feedback